Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effects of Silymarin Supplementation on Metabolic Status and Oxidative Stress in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Clinical Trials Publisher Pubmed



Hadi A1 ; Pourmasoumi M2 ; Mohammadi H1 ; Symonds M3, 4 ; Miraghajani M3, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Students’ Research Committee, Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Gastrointestinal & Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences, Rasht, Iran
  3. 3. Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran e Early Life Research Unit, Division of Child Health, Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham, United Kingdom
  4. 4. Nottingham Digestive Disease Centre and Biomedical Research Centre, School of Medicine, University of Nottingham, Nottingham, United Kingdom
  5. 5. Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  6. 6. Cancer research center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Complementary Therapies in Medicine Published:2018


Abstract

Objective: The effect of silymarin supplementation on metabolic status and oxidative stress of subjects with type 2 diabetes mellitus (T2DM) has not been conclusively studied. Therefore, the efficacy of silymarin supplementation in these patients was assessed through a meta-analysis. Methods: The following databases were searched up to May 15, 2018: PubMed, Scopus, Ovid (Cochrane library), Google scholar and ISI web of science. All randomized clinical trials using silymarin supplements to improve T2DM included in this meta-analysis. Mean Difference (MD) was pooled using a random-effects model. Results: Eight eligible publications from seven trials were identified for the present meta-analysis. Our results revealed that supplementation with silymarin can decrease fasting blood sugar, hemoglobin A1C, insulin, low-density lipoprotein cholesterol and malondialdehyde and increase high-density lipoprotein cholesterol levels. However, silymarin did not have any significant effects on total cholesterol or triglyceride concentrations. Conclusion: Our data suggest that silymarin supplements have beneficial effects on metabolic status and oxidative stress among patients with T2DM. However, there is currently insufficient evidence to make firm conclusions about the full efficacy of supplementation. © 2018
Other Related Docs